|
Re: One monkey off....
|
7
|
Resverlogix Corp.
|
Jul 22, 2020 09:55AM
|
|
Re: Is this sleeping beauty
|
8
|
Resverlogix Corp.
|
Jul 16, 2020 07:27PM
|
|
Re: The Biotech Blindspot
|
5
|
Resverlogix Corp.
|
Jul 04, 2020 07:08PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:27PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 06:10PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
4
|
Resverlogix Corp.
|
Jun 22, 2020 05:54PM
|
|
Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study
|
2
|
Resverlogix Corp.
|
Jun 22, 2020 05:45PM
|
|
Re: Zenith a Loser Too
|
6
|
Resverlogix Corp.
|
Jun 17, 2020 06:59AM
|
|
Re: Zenith A Loser Too
|
7
|
Zenith Epigenetics
|
Jun 16, 2020 03:18PM
|
|
Re: Zenith Announces Corporate Update Conference Call & Webcast on June 18, 2020 and US$5 Million Equity Investment
|
4
|
Zenith Epigenetics
|
Jun 16, 2020 08:54AM
|
|
Re: Revised target market, indications, market potential? ... and some numbers?
|
7
|
Resverlogix Corp.
|
Jun 14, 2020 11:56AM
|
|
Re: Still waiting for that BETonMACE CKD sub-study 7 months later
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 04:44PM
|
|
Re: Rough Transcript - Resverlogix Corporate Update and Conference Call - 06/10/2020
|
2
|
Resverlogix Corp.
|
Jun 11, 2020 09:39AM
|
|
Re: Merrill Lynch
|
4
|
Resverlogix Corp.
|
Jun 09, 2020 06:04PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
2
|
Resverlogix Corp.
|
May 14, 2020 05:16PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
5
|
Resverlogix Corp.
|
May 14, 2020 10:37AM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
6
|
Resverlogix Corp.
|
May 14, 2020 09:33AM
|
|
Cytovance
|
1
|
Resverlogix Corp.
|
Apr 13, 2020 11:34AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
5
|
Resverlogix Corp.
|
Mar 31, 2020 05:52PM
|
|
Re: Trials and statistics, next steps
|
3
|
Resverlogix Corp.
|
Feb 11, 2020 04:21PM
|
